Clinical Trials · NCT01755858
Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery
- Phase
- Phase 1/Phase 2
- Recruitment status
- Terminated
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 16
- Start date
- Dec 2012
- Locations
- 1 site, United States
- Primary endpoint
- Change in Mean Glomerular Filtration Rate (GFR), as Measured by Iothalamate Clearance, at Baseline (Pre-percutaneous Renal Artery Angioplasty and 8 Weeks Post-PTRA.